The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast
Abstract The identification of actionable biomarkers and development of targeted therapies have revolutionized the field of lung cancer treatment. In patients with advanced non-small cell lung cancer (NSCLC), biomarker testing can inform selection of effective targeted therapies as well as avoid the...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-03-01
|
Series: | Oncology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40487-024-00271-w |